BHRS Policies & Forms

Link to BHRS Policies & Forms
Avatar Instructions to find HEALTHsuite Number (HSN)
Medication Monitoring Policy
Medication Monitoring Checklist--fillable
BHRS FDA Guidelines for Indications and Dosage Ranges
 

Laboratory References

Lab Guide
CBC non-included MH Dx
HBA1c NCD Dx
HCG test NCD Dx
LabCorp Drugs of Abuse Testing LCD
LCD for MolDx HLA-B* 15 02 Genetic Testing
Lipid Panel NCD Dx
Medi-Cal Dx for Vitamin B12
Prolactin ICD10 codes CA MediCal
Pharmacogenetic Test Protocol and Request
Thyroid Test NCD Dx
Vitamin D 25 hydroxy

Medication and Assessment Forms

AIM SCALE
Brief Psychiatric Rating Scale (BPRS)
Lab Weight Chart
Montreal Cognitive Assessment (MOCA)
Prior Authorization Request Form

Prescribing References

Atypical Antipsychotic LAI Comparison
BHRS Formulary
BHRS PA Procedures and Criteria
Clozapine Guidelines
Clozapine Flowchart
Management of Neuropsychiatric Symptoms in Dementia
Medi-Cal Covered Drug List (CDL) for Psychotropics
Methadone and QTc Prolongation
Psychotropics Available in Liquid or ODT formulations

Medication Guidelines from LA DMH with permission
Antidepressant Medications 
Antipsychotic Medications 
Anxiolytic Medications
Mood Stabilizing Medications
Psychotropic Medications in Youth

Treatment Guidelines

ADHD/Stimulants

ADHD Medications
ADHD Protocol for Adults seeking services at BHRS
Adult ADHD Treatment Guidelines
Controlled Medication Agreement – EnglishSpanish
Controlled Medication Guidelines

Benzodiazepines/Hypnotics

Alternatives to Benzodiazepines in Insomnia/Anxiety
Benzodiazepines Client Education Sheet – English Spanish
Benzodiazepines Dosing & PK
Benzodiazepines and Z Drugs Guidelines
Controlled Medication Agreement – EnglishSpanish
Controlled Medication Guidelines
Sleep Medication Client Handout
 

Medication-Assisted Treatment

Buprenorphine-Naloxone Protocol
Buprenorphine-Naloxone Patient Information
Narcan Spray Brochure — Narcan EnglishNarcan Spanish
Narcan vs Kloxxado
Reduce Heavy Alcohol Use Dosing Recommendations
Reduce Heavy Alcohol Use Flowchart
Urge to Drink Scale – EnglishSpanish
Smoking Cessation Guidelines
Vivitrol Protocol for AUD

Newer Medications Reviewed by P & T Committee

Abilify Asimtufii (Aripiprazole LAI)
Abilify Mycite (Aripiprazole Digital System)
Aristada (Aripiprazole Lauroxil)
Aristada Initio (Aripiprazole Lauroxil)
Auvelity (Dextromethorphan-Bupropion)
Brixadi (Buprenorphine LAI)
Caplyta (Lumateperone)
Cobenfy (Xanomeline and Trospium)
Dayvigo (Lemborexant)
Erzofri (Paliperidone Palmitate)
Fetzima (Levomilnacipran)
Hetlioz (Tasimelteon)
Igalmi (Dexmetetomedine)
Invega Hafyera (Paliperidone Palmitate)
Invega Trinza (Paliperidone Palmitate)
Lybalvi (Olanzapine and Samidorphan)
Nuplazid (Pimavanserin)
Opvee (Nalmefene)
Paxlovid Drug Interactions with Psychotropics
Perseris (Risperidone LAI)
Qelbree (Viloxazine)
Quviviq (Daridorexant)
Rexulti (Brexpiprazole)
Rykindo (Risperidone Microsphere)
Secuado (Asenapine Patch)
Spravato (Ketamine Nasal Spray)
Sublocade (Buprenorphine LAI)
Uzedy (Risperidone LAI)
Trintellix (Vortioxetine)
VMAT-2 Inhibitors (Austedo, Ingrezza)
Vraylar (Cariprazine)
Wakefulness Promoting Agents
Xelstrym (Dextroamphetamine Transdermal)
Zulresso (Brexanolone)
Zursuvae (Zuranolone)

Information Use Only

BHRS Position Statement on Ketamine
Ketamine Consensus Statement by APA 2017
BHRS Position Statement on Medical Marijuana
BHRS Position Statement on the Use of Psychedelics in Psychiatry
Compounding Pharmacies
     Psychotropics Available in Liquid or ODT formulations